Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $202.22

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have earned a consensus recommendation of “Moderate Buy” from the twenty-two research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have given a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $202.2222.

A number of analysts have recently commented on ALAB shares. Royal Bank Of Canada began coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Citigroup decreased their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Morgan Stanley restated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities lifted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Finally, Raymond James Financial initiated coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating for the company.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares in the company, valued at approximately $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 226,792 shares of company stock worth $28,001,069. Corporate insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares during the period. State Street Corp lifted its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after acquiring an additional 760,358 shares during the period. Geode Capital Management LLC lifted its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after acquiring an additional 104,935 shares during the period. Fred Alger Management LLC grew its stake in shares of Astera Labs by 25.5% in the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Finally, Morgan Stanley grew its stake in shares of Astera Labs by 33.0% in the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after purchasing an additional 480,009 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 1.0%

Shares of Astera Labs stock opened at $126.34 on Monday. The company has a fifty day simple moving average of $145.64 and a 200-day simple moving average of $166.93. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The stock has a market cap of $21.50 billion, a price-to-earnings ratio of 103.56, a PEG ratio of 2.51 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. During the same period last year, the business earned $0.37 EPS. Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts forecast that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.